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Abstract
Many harmful species of bacteria have evolved to gain
resistance to most common antibiotics, leading to infections
that are very hard to treat because of the overuse of
antibiotics. As a solution for this problem, we are using phage
therapy and evolution to our advantage. Bacteriophage (also
called phage) are viruses that infect and replicate within
bacteria and archaea. In this poster, I will describe the
different experiments that I have conducted into developing a
new therapy in my internship with Felix Biotechnology that
could save us from the next global problem.
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“Antibiotic resistance is one of the biggest threats to
global health, food security, and development today.
Antibiotic resistance can affect anyone, of any age, in
any country.
Antibiotic resistance occurs naturally, but misuse of
antibiotics in humans and animals is accelerating the
process.
A growing number of infections – such as pneumonia,
tuberculosis, gonorrhea, and salmonellosis – are
becoming harder to treat as the antibiotics used to treat
them become less effective.
Antibiotic resistance leads to longer hospital stays,
higher medical costs and increased mortality.”

From the WHO (World Health Organization) website
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Phage therapy is the use of
bacteriophages to treat
bacterial infections. In the
process of phage therapy
the
bacteriophage
will
select the bacteria that will
be infected. Through time,
bacteria will gain resistance
to bacteriophages and lose
Sensitive to
the resistance to antibiotic.
Bacteriophages
Here is were we use
evolution to our advantage
and treat these new
infections with antibiotics
and the cycle repeats.

Processing Steps Continuation

Technology used

Titration

Next Generation sequencing
With its ultra-high throughput, scalability, and
speed, we can perform a wide variety of
applications and studies, like understanding
the sequences in bacteria that make them
resistant to antibiotics and how to possibly
fight them with phage therapy.
By Illumina.com
Processing Steps
Genomic Sequencing

Titration is an experiment where a known property of one solution is used to infer an
unknown property of another solution with the same sample. First, we do a culture of bacteria
and phage sample and let them grow overnight. Later we prepare plates with LB agar and
mix the grown bacteria culture into LB top agar which have a lower percentage of agar than
LB agar. We pour this mixture on top of the prepared plates to create a bacterial lawn. With
the phages we do a serial dilution of 10-fold, after the serial dilution is done, we pipet each
dilution on top of the bacterial lawn to create plaques. We let it incubate overnight to later see
results and we are expecting for clear plaques which indicates that the phages attacked the
bacteria.
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The purpose of genomic sequencing is to extract the genome from the bacteria and understand
what makes them resistant to antibiotics and how we can eliminate the infection. To prepare
bacteria for next-generation sequencing, the bacteria are grown in media over night, then we
centrifuge the bacteria to create a pellet, then we do a dynamic DNA prep which consists of
extracting DNA from the bacteria, and later we quantify the DNA using calculations before we do
the library prep. Finally, we do a library prep and then sequence our samples.
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In this experiment we wanted to
determine what are the best
conditions to grow bacteriophages.
The first condition was if the if
bacteriophages prefer to grow in
liquid (Q) or in plaques (P). Second
condition was if we prime the tips
(+) before titration or not (-). We
tested this conditions with two
different bacteriophages. In these
results, we can see that Phage 1
prefers to grow in plaque over liquid
medium. With the titration we see
that after -6 dilution it losses
potency and is not effective against
the bacteria. Phage 2 we see that
even at -8 dilutions it is still very
potent against the bacteria. Finally,
in Phage 1 and Phage 2 we see
that there were no difference in the
plaques when it comes to prime or
not prime the tips before titration .
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